Tag: imlifidase
Transplanting the “untransplantable”: French guidelines open doors for imlifidase
A “major breakthrough in kidney transplantation”—that is how imlifidase has been described in new French consensus guidelines on the drug’s use that have been...
Scottish Medicines Consortium recommends Idefirix for highly sensitised kidney transplant patients
Hansa Biopharma recently announced a recommendation by the Scottish Medicines Consortium (SMC) for its “first-in-class” treatment Idefirix (imlifidase) in the desensitisation of highly sensitised adult...
NICE recommends Idefirix in treatment of highly sensitised kidney transplant recipients
Hansa Biopharma has announced a recommendation by the National Institute for Health and Care Excellence (NICE) for its first-in-class treatment Idefirix (imlifidase) in the...
Hansa Biopharma enrols first patient in US pivotal trial of kidney...
Hansa Biopharma recently announced that the first patient has been enrolled in its CONFIDES trial—a US pivotal, open-label, randomised controlled study—at the Columbia University Medical Center...